2.9546
price down icon3.45%   -0.1054
 
loading
Schlusskurs vom Vortag:
$3.06
Offen:
$3.08
24-Stunden-Volumen:
131.08K
Relative Volume:
0.38
Marktkapitalisierung:
$130.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.0477
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
-0.86%
1M Leistung:
-5.61%
6M Leistung:
-42.85%
1J Leistung:
+40.69%
1-Tages-Spanne:
Value
$2.92
$3.08
1-Wochen-Bereich:
Value
$2.87
$3.10
52-Wochen-Spanne:
Value
$1.595
$10.48

Protara Therapeutics Inc Stock (TARA) Company Profile

Name
Firmenname
Protara Therapeutics Inc
Name
Telefon
646-844-0337
Name
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Name
Mitarbeiter
33
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
TARA's Discussions on Twitter

Vergleichen Sie TARA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TARA
Protara Therapeutics Inc
2.955 130.02M 0 -42.05M -35.26M -2.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.69 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
519.58 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.19 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
561.33 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.50 28.51B 3.81B -644.79M -669.77M -6.24

Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-16 Eingeleitet Scotiabank Sector Outperform
2025-03-14 Eingeleitet Cantor Fitzgerald Overweight
2023-07-10 Fortgesetzt Guggenheim Buy
2021-06-04 Eingeleitet H.C. Wainwright Buy
2021-02-17 Eingeleitet Oppenheimer Outperform
2020-10-19 Eingeleitet Cowen Outperform
2020-07-29 Eingeleitet Guggenheim Buy
Alle ansehen

Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten

pulisher
Jun 16, 2025

Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Why EchoStar Stock Is Soaring Higher Today - The Globe and Mail

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Cuts Stock Holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Protara Therapeutics: Marching On To A Hopefully Eventful Back Half Of 2025 (NASDAQ:TARA) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

SoundHound AI (SOUN): This High-Potential Growth Stock Could Be Your Smartest Bet under $10 - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

Where Will Uber Stock Be in 5 Years? - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

Company News for Jun 13, 2025 - The Globe and Mail

Jun 13, 2025
pulisher
Jun 12, 2025

Protara Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

These 3 ‘Bro Billionaire’ Stocks Are Wildly Outperforming in Trump’s Market - The Globe and Mail

Jun 12, 2025
pulisher
Jun 11, 2025

Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts TARA FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Makes New $110,000 Investment in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Steven Hudson buying at ECN Capital (ECN) - The Globe and Mail

Jun 09, 2025
pulisher
Jun 07, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Position Increased by Bank of America Corp DE - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Given Average Recommendation of “Buy” by Analysts - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Why Shares of Tesla Are Sinking Today - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Is Costco a Buy Now? - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Purchases 357,051 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Protara Therapeutics (TARA) Appoints New Chief Commercial Officer | TARA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics names new Chief Commercial Officer - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Names William Conkling as Chief Commercial Officer - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment Of William Conkling As Chief Commercial Officer - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment of William Conkling a - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

The Next Stock I'm Buying? - The Globe and Mail

May 31, 2025
pulisher
May 29, 2025

Transcript : Protara Therapeutics, Inc. Presents at TD Cowen's 6th Annual Oncology Innovation Summit, May-27-2025 01 - marketscreener.com

May 29, 2025
pulisher
May 22, 2025

Jones Trading Initiates Coverage of Protara Therapeutics (TARA) with Buy Recommendation - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Initiates Coverage with a Buy Rating - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Initiates Coverage with a Buy Rating | TARA Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Receives Buy Rating with $21 Price T - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Jones Initiates Protara Therapeutics at Buy With $21 Price Target - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Richard Levy Spends US$64k On Protara Therapeutics Stock - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

BNP Paribas Financial Markets Purchases Shares of 151,906 Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 22, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Makes New $111,000 Investment in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 18, 2025
pulisher
May 17, 2025

Richard Levy Bought 65% More Shares In Protara Therapeutics - simplywall.st

May 17, 2025
pulisher
May 17, 2025

Insider Buying: Richard Levy Acquires 20,000 Shares of Protara T - GuruFocus

May 17, 2025
pulisher
May 16, 2025

With 73% ownership, Protara Therapeutics, Inc. (NASDAQ:TARA) boasts of strong institutional backing - Yahoo Finance

May 16, 2025
pulisher
May 13, 2025

Protara Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 13, 2025
pulisher
May 11, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of “Buy” from Brokerages - Defense World

May 11, 2025
pulisher
May 10, 2025

Protara Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 10, 2025
pulisher
May 09, 2025

Protara Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Barclays PLC Takes $492,000 Position in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 09, 2025
pulisher
May 08, 2025

Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC with Strong Efficacy and Safety Profile - TipRanks

May 08, 2025
pulisher
May 08, 2025

Protara (TARA) Strengthens Leadership with Key Appointments | TA - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics (TARA) Sees Positive Results in TARA-002 Trial | TARA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara (TARA) Strengthens Leadership with Key Appointments | TARA Stock News - GuruFocus

May 08, 2025

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Protara Therapeutics Inc-Aktie (TARA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Zummo Jacqueline
Chf Scientific Operations Off
Mar 26 '25
Sale
4.53
21,224
96,145
98,861
$20.45
price down icon 1.42%
$35.80
price down icon 0.93%
$20.63
price down icon 1.48%
$105.47
price down icon 0.48%
$103.26
price down icon 1.73%
biotechnology ONC
$267.50
price up icon 0.41%
Kapitalisierung:     |  Volumen (24h):